Harel Insurance Investments & Financial Services Ltd. Has $6.80 Million Holdings in Cencora, Inc. $COR

Harel Insurance Investments & Financial Services Ltd. trimmed its stake in Cencora, Inc. (NYSE:COR) by 11.6% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,640 shares of the company’s stock after selling 2,828 shares during the period. Harel Insurance Investments & Financial Services Ltd.’s holdings in Cencora were worth $6,798,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Kemnay Advisory Services Inc. acquired a new stake in Cencora during the fourth quarter worth $25,000. Oakworth Capital Inc. bought a new position in shares of Cencora in the fourth quarter valued at approximately $26,000. Elyxium Wealth LLC acquired a new position in shares of Cencora in the 4th quarter worth approximately $27,000. Archer Investment Corp grew its position in Cencora by 134.3% during the 4th quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after acquiring an additional 47 shares during the last quarter. Finally, Motiv8 Investments LLC acquired a new stake in Cencora during the 4th quarter valued at $29,000. Institutional investors own 97.52% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. Wells Fargo & Company decreased their target price on Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a report on Monday, May 11th. Citigroup dropped their target price on shares of Cencora from $405.00 to $355.00 and set a “buy” rating for the company in a research note on Thursday, May 7th. Morgan Stanley set a $342.00 price target on shares of Cencora in a research note on Friday, May 8th. Evercore set a $360.00 price objective on Cencora in a report on Wednesday, April 8th. Finally, William Blair assumed coverage on Cencora in a research report on Tuesday, April 28th. They issued a “market perform” rating on the stock. Eleven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $367.75.

Insider Buying and Selling at Cencora

In other news, Director Lauren M. Tyler acquired 550 shares of Cencora stock in a transaction on Monday, June 22nd. The shares were purchased at an average cost of $270.23 per share, for a total transaction of $148,626.50. Following the completion of the purchase, the director directly owned 4,359 shares of the company’s stock, valued at approximately $1,177,932.57. This represents a 14.44% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 0.38% of the company’s stock.

Cencora Trading Down 1.8%

NYSE COR opened at $296.71 on Thursday. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59. The stock’s 50-day moving average is $277.99 and its 200-day moving average is $317.98. Cencora, Inc. has a one year low of $244.82 and a one year high of $377.54. The firm has a market cap of $57.73 billion, a P/E ratio of 22.75, a P/E/G ratio of 1.68 and a beta of 0.58.

Cencora (NYSE:COR) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). The company had revenue of $78.36 billion during the quarter, compared to the consensus estimate of $81.09 billion. Cencora had a net margin of 0.78% and a return on equity of 135.20%. The firm’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Sell-side analysts anticipate that Cencora, Inc. will post 17.79 earnings per share for the current fiscal year.

Cencora Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date was Friday, May 15th. Cencora’s dividend payout ratio is presently 18.40%.

Cencora declared that its Board of Directors has initiated a stock buyback plan on Thursday, May 21st that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the company to purchase up to 3.9% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s board believes its stock is undervalued.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.